Rayner designs and manufactures intraocular lenses and proprietary injection devices for use in cataract surgery. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention.With more than 65 years of continuous growth and experience, we remain at the forefront of innovation. Weare focused on providing the best IOLs for clinicians and patients and are driven by science to improve patient outcomes and safety.Primary IOLs Our FDA-approved C-flex aspheric (aberration-neutral) monofocal IOL, as well as our toric and multifocal IOL families are now complemented by the RayOne fully preloaded monofocal IOL injection system. Supplementary IOLsDesigned to be implanted in the ciliary sulcus, Rayner Sulcoflex Pseudophakic Supplementary IOLs are available as aspheric, toric, multifocal and multifocal lenses, and offer a reversible solution for correcting residual post-operative refractive errors following the implantation of a conventional IOL in the capsular bag.OVDsOur Ophteis range offers a full spectrum of OVDs from dispersive to cohesive, enabling surgeons to select the OVD best suited to each specific cataract procedure. Ophteis FR Pro with sorbitol -- designed to deliver a new level of corneal endothelial protection from phaco induced trauma -- is the flagship product of Rayner’s ‘Ophteis’ OVD suite. PharmaceuticalsAlthough the intraocular lens plays a leading role in the visual outcomes of cataract and refractive surgery, the pharmaceuticals that manage the tear film and inflammation are critical to the end result. For that reason, Rayner recently acquired the business of Moorfields Pharmaceuticals. The acquisition will enable us to offer an even wider range of ophthalmic tools that aid and streamline the surgical process whilst remaining focused on the visual outcome for the patient.Rayner markets its IOL portfolio and related products worldwide through a network of distributors in over 80 countries with direct markets in UK, Germany & Austria, the United States of America, Italy and Spain. We have the world’s longest commercial history of IOL design and manufacturing and have worked with cataract surgeons for longer than anyone else.In 2016, Rayner transferred its global headquarters to a brand new state of the art manufacturing plant, which has dramatically increased the company’s production capacity.

Health Care

Medical Devices

Rayner

Tim Clover

Jean Callaghan

Wade Allen

Thomas Heron

Nathaniel Davies

Lee Neal

Kuntal Joshi

Jim Nevelos PhD FRSA FIMechE

James Crutchlow

Graham Pescod

Geoff Allan

Gabriela Spinola, MEng, AMIChemE

Elodie Rottier

David Forsythe

Daniel Purchase

Claire Rendell (FCIPD)

Christopher Willis

Cary E. Dawes

Alan Krol

Alan Hemmant

The Sales and Business Development team at Rayner is responsible for driving revenue growth and expanding market presence globally. This involves strategizing and implementing sales initiatives, managing distributor relationships, identifying new business opportunities, and providing training to ensure optimal sales performance. The team's objective is to enhance the reach of Rayner's innovative intraocular lenses, injection devices, and ophthalmic tools in over 80 countries, ensuring superior patient outcomes and safety.

Sales and Business Development

Sales Team

Engineering Team

Leadership Team

Sales and Business Development

About

Team members

Other teams at Rayner

Sales Team

Engineering Team

Leadership Team